gms | German Medical Science

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. - 14. Mai 2014, Dresden

The age of collagen in intracranial saccular aneurysms

Meeting Abstract

  • Nima Etminan - Klinik für Neurochirurgie, Heinrich-Heine Universität, Düsseldorf
  • Rita Dreier - Institut für Physiologische Chemie and Pathobiochemie, Westfälische Wilhelms-Universität, Münster
  • Bruce A. Buchholz - Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, California, USA
  • Kerim Beseoglu - Klinik für Neurochirurgie, Heinrich-Heine Universität, Düsseldorf
  • Christian Matzenauer - Institut für Rechtsmedizin, Heinrich-Heine Universität, Düsseldorf
  • Peter Bruckner - Institut für Physiologische Chemie and Pathobiochemie, Westfälische Wilhelms-Universität, Münster
  • James C. Torner - Department of Epidemiology, University of Iowa, Iowa City, Iowa, USA
  • Hans-Jakob Steiger - Klinik für Neurochirurgie, Heinrich-Heine Universität, Düsseldorf
  • Daniel Hänggi - Klinik für Neurochirurgie, Heinrich-Heine Universität, Düsseldorf
  • R. Loch Macdonald - Division of Neurosurgery, St. Michael’s Hospital,University of Toronto, Toronto, Canada

Deutsche Gesellschaft für Neurochirurgie. 65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Dresden, 11.-14.05.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocMO.02.01

doi: 10.3205/14dgnc001, urn:nbn:de:0183-14dgnc0015

Veröffentlicht: 13. Mai 2014

© 2014 Etminan et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: The natural history of cerebral aneurysms (CAs), especially how long CAs may have existed before clinical presentation, remains incompletely understood and controversial. We used radiocarbon birth dating to measure the age of collagen, which is the main constituent of CAs, as an indicator for biosynthesis and turnover of CAs.

Method: Forty-six CA samples from 43 patients undergoing surgical repair of ruptured or unruptured CAs were obtained. Collagen I was purified from CA samples and 14C levels were measured by accelerator mass spectrometry. The estimated CA collagen ages were correlated with CA rupture status and factors, which have been associated with aneurysm progression and rupture. Collagen extracted from mouse tendons served as controls. Ten intracerebral and 2 extracerebral arteries from human cadavers were used to estimate physiological collagen I-turnover in relation to aneurysms.

Results: Nearly all CA collagen samples were less than 5 years old, irrespective of patient age, CA size, morphology, or rupture status. However, CAs from patients with a history of cardiovascular risk factors, e.g. smoking or hypertension, contained significantly younger collagen, compared to CAs from patients with no risk factors (mean 1.6 ± 1.2 years versus 3.9 ± 3.3 years, respectively, p= 0.012). The collagen samples from mouse tendons confirmed the validity of the method since all of these samples gave F14C values for collagen corresponding to the F14C values of the mouse chow fed to the animals (data not shown). The 12 samples from the human cerebral arteries did not yield substantial amounts of collagens I or V.

Conclusions: Our data indicate that the main constituent of CAs is relatively and consistently young when detected, suggesting that there is ongoing collagen remodeling in CAs, which is accelerated in patients with risk factors. Additionally, the analysis of the human cerebral arteries suggests a distinctly lower biosynthesis and/or turnover of collagens I and V, compared to CAs. Our results challenge the prevailing opinion that CAs can be present for decades and that they only undergo sporadic episodes of structural change. Moreover, our results support modification of risk factors and more frequent follow-up of patients with conservatively managed CAs and concomitant risk factors.